Regulon

Regulon: R-398

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.6865514Pr-133Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
9168 ENSG00000034510 TMSB10 P63313
841 ENSG00000064012 CASP8 Q14790
29957 ENSG00000085491 SLC25A24 Q6NUK1
10312 ENSG00000110719 TCIRG1 Q13488
7045 ENSG00000120708 TGFBI Q15582
51303 ENSG00000134285 FKBP11 Q9NYL4
3601 ENSG00000134470 IL15RA K9N1J3
3688 ENSG00000150093 ITGB1 P05556
831 ENSG00000153113 CAST P20810
840 ENSG00000165806 CASP7 P55210
302 ENSG00000182718 ANXA2 P07355
375035 ENSG00000213064 SFT2D2 O95562
123803 ENSG00000275779 NTAN1 H3BNJ5

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ATN-161ITGB3ProteinANTAGONISTIntegrin alpha-5/beta-1 antagonist20
NIVOCASANCASP1Small moleculeINHIBITORCaspase-9 inhibitor20
NATALIZUMABITGA4AntibodyINHIBITORIntegrin alpha-4/beta-1 inhibitor40
FIRATEGRASTITGB1Small moleculeANTAGONISTIntegrin alpha-4/beta-1 antagonist20
EMRICASANCASP4Small moleculeINHIBITORCaspase inhibitor20
VOLOCIXIMABITGB1AntibodyANTAGONISTIntegrin alpha-5/beta-1 antagonist30
RECOMBINANT HUMAN INTERLEUKIN-15IL2RBUnknownAGONISTInterleukin-15 receptor agonist20
ABITUZUMABITGAVAntibodyINHIBITORIntegrin alpha-V/beta-5 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-398

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00253CDC27down-regulatesIRF8activatesR-398181Drugs (8)
CMF-04306RBPJLup-regulatesIRF8activatesR-398186Drugs (8)
CMF-14764SLC5A12up-regulatesIRF8activatesR-398184Drugs (8)
CMF-28742SYN3down-regulatesIRF8activatesR-398184Drugs (8)